Value-Based Differential Pricing: Efficient Prices for Drugs in a Global Context von Danzon, Patricia, Towse, Adrian, Mestre-Ferrandiz, Jorge

Volltext

Why has therapy development for dementia failed in the last two decades? von Gauthier, Serge, Albert, Marilyn, Fox, Nick, Goedert, Michel, Kivipelto, Miia, Mestre-Ferrandiz, Jorge, Middleton, Lefkos T

Volltext

Disease burden and economic impact of diagnosed non‐alcoholic steatohepatitis in five European countries in 2018: A cost‐of‐illness analysis von Schattenberg, Jörn M., Lazarus, Jeffrey V., Newsome, Philip N., Serfaty, Lawrence, Aghemo, Alessio, Augustin, Salvador, Tsochatzis, Emmanuel, Ledinghen, Victor, Bugianesi, Elisabetta, Romero‐Gomez, Manuel, Bantel, Heike, Ryder, Stephen D., Boursier, Jerome, Leroy, Vincent, Crespo, Javier, Castera, Laurent, Floros, Lefteris, Atella, Vincenzo, Mestre‐Ferrandiz, Jorge, Elliott, Rachel, Kautz, Achim, Morgan, Alice, Hartmanis, Sally, Vasudevan, Sharad, Pezzullo, Lynne, Trylesinski, Aldo, Cure, Sandrine, Higgins, Victoria, Ratziu, Vlad

Volltext

Parent's perception of respiratory syncytial virus and subsequent wheezing burden: A multi‐country cross‐sectional survey von Custovic, Adnan, Mestre‐Ferrandiz, Jorge, Kragten‐Tabatabaie, Leyla, Laurent, Julie, Sellem, Laury, Koslap‐Petraco, Mary, Cadeddu, Chiara

Volltext

Comparing access to orphan medicinal products in Europe von Zamora, Bernarda, Maignen, Francois, O'Neill, Phill, Mestre-Ferrandiz, Jorge, Garau, Martina

Volltext

An analysis of orphan medicine expenditure in Europe: is it sustainable? von Mestre-Ferrandiz, Jorge, Palaska, Christina, Kelly, Tom, Hutchings, Adam, Parnaby, Adam

Volltext

Evaluation of antibody-based preventive alternatives for respiratory syncytial virus: a novel multi-criteria decision analysis framework and assessment of nirsevimab in Spain von Mestre-Ferrándiz, Jorge, Rivero, Agustín, Orrico-Sánchez, Alejandro, Hidalgo, Álvaro, Abdalla, Fernando, Martín, Isabel, Álvarez, Javier, García-Cenoz, Manuel, Del Carmen Pacheco, Maria, Garcés-Sánchez, María, Zozaya, Néboa, Ortiz-de-Lejarazu, Raúl

Volltext

Projecting Pharmaceutical Expenditure in EU5 to 2021: Adjusting for the Impact of Discounts and Rebates von Espin, Jaime, Schlander, Michael, Godman, Brian, Anderson, Pippa, Mestre-Ferrandiz, Jorge, Borget, Isabelle, Hutchings, Adam, Flostrand, Steven, Parnaby, Adam, Jommi, Claudio

Volltext

Does NICE influence the adoption and uptake of generics in the UK? von Serra-Sastre, Victoria, Bianchi, Simona, Mestre-Ferrandiz, Jorge, O’Neill, Phill

Volltext

Expert-based collaborative analysis of the situation and prospects of biomarker test implementation in oncology in Spain von Mestre-Ferrándiz, Jorge, Franch Camino, Blanca, Hidalgo, Álvaro, del Llano Núñez-Cortés, Alicia, del Llano Señarís, Juan Ernesto, Lumbreras, Blanca, Beas Pedraza, David, Nuño-Solinís, Roberto, Paz-Ares, Luis, Ramón y Cajal, Santiago, Rodríguez, Miguel Javier

Volltext

Public health policies for the common interest: rethinking EU states’ incentives strategies when a pandemic reshuffles all interests von Del Llano, Juan, Mestre-Ferrandiz, Jorge, Espin, Jaime, Gol-Montserrat, Jordi, del Llano, Alicia, Bringas, Carlos

Volltext

Impact of twelve immunization-preventable infectious diseases on population health using disability-adjusted life years (DALYs) in Spain von Pérez-Rubio, Alberto, Mestre-Ferrandiz, Jorge, López-Belmonte, Juan Luis, Diaz-Aguiló, Ariadna, Lorenzo-Herrero, Seila, Crespo, Carlos

Volltext

A Review of Current Approaches to Evaluating and Reimbursing New Medicines in a Subset of OECD Countries von Zozaya, Néboa, Villaseca, Javier, Fernández, Irene, Abdalla, Fernando, Cadenas-Noreña, Benito, Calleja, Miguel Ángel, Gómez-Pajuelo, Pedro, Mestre-Ferrándiz, Jorge, Oliva-Moreno, Juan, Trillo, José Luis, Hidalgo-Vega, Álvaro

Volltext

New pricing models for generic medicines to ensure long-term sustainable competition in Europe von Francois, Clement, Gawlik, Gabriela, Mestre-Ferrandiz, Jorge, Pana, Adrian, Perelman, Julian, Yfantopoulos, John, Simoens, Steven

Volltext

Not one, but many: developing a multi-indication pricing model for medicines in Belgium von Maes, Ingrid, Kok, Eline, De Torck, Pieter-Jan, Mestre-Ferrandiz, Jorge, Simoens, Steven

Volltext

Collaboration for new therapies: maximizing health and innovation von Mestre-Ferrandiz, Jorge, Meulien, Pierre, Ostwald, Dennis A, Acha, Virginia

Volltext

How Much Does It Cost to Research and Develop a New Drug? A Systematic Review and Assessment von Schlander, Michael, Hernandez-Villafuerte, Karla, Cheng, Chih-Yuan, Mestre-Ferrandiz, Jorge, Baumann, Michael

Volltext

Talkin’ About a Resolution: Issues in the Push for Greater Transparency of Medicine Prices von Shaw, Brendan, Mestre-Ferrandiz, Jorge

Volltext

European Union Pharmaceutical Markets: A Case for Differential Pricing? von Towse, Adrian, Pistollato, Michele, Mestre-Ferrandiz, Jorge, Khan, Zeba, Kaura, Satyin, Garrison, Louis

Volltext

Biosimilars: How Can Payers Get Long-Term Savings? von Mestre-Ferrandiz, Jorge, Towse, Adrian, Berdud, Mikel

Volltext